NUS Yong Loo Lin School of Medicine/LinkedIn
Jun 24, 2025, 09:42
Wee Joo Chng: Resistance to immunomodulatory drugs in multiple myeloma – the cereblon pathway and beyond
Wee Joo Chng, Professor in Medical Oncology at the National University of Singapore, shared a post on LinkedIn:
“Happy to share a paper from my group that was recently published in Hematologica. In this paper, we summarises the current knowledge on the mechanisms of resistance to immunomodulatory drugs In myeloma. These drugs are mainstay in myeloma treatment. Resistance is an important mechanism for treatment failure, so understanding the biology and rationally designing strategies to overcome resistance is important.”
Title: Resistance to immunomodulatory drugs in multiple myeloma: the cereblon pathway and beyond
Authors: Phaik Ju Teoh, Mun Yee Koh, Constantine Mitsiades, Sarah Gooding, Wee Joo Chng
Read the Full Article.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 26, 2025, 14:58
Jul 26, 2025, 13:46
Jul 26, 2025, 13:34
Jul 26, 2025, 13:25
Jul 26, 2025, 13:07